Pierre Quartier researcher
Quartier, Pierre, 19..., médecin
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
VIAF ID: 316665405 (Personal)
Permalink: http://viaf.org/viaf/316665405
Preferred Forms
4xx's: Alternate Name Forms (4)
Works
| Title | Sources |
|---|---|
| Accès aux soins et parcours diagnostique des patients atteints d'arthrite juvénile idiopathique |
|
| Access to pediatric rheumatology care and diagnostic pathway in Juvenile idiopathic arthritis (JIA). |
|
| Complications orthopédiques à l'ère des biothérapies dans la forme systémique d'arthrite juvénile idiopathique |
|
| Efficacité et tolérance des agents biologiques dans les rhumatismes inflammatoires à début juvénile dans les essais cliniques randomisés et les études observationnelles |
|
| Efficacité et tolérance d'un traitement de première ligne par corticoïdes et méthotrexate dans la dermatomyosite juvénile : une étude de cohorte rétrospective |
|
| Efficacy and safety of biological agents in juvenile inflammatory rheumatic diseases : from randomized clinical trials and observational studies. |
|
| Identifying genetic causes of pediatric Evans syndrome. |
|
| The lung is involved in juvenile dermatomyositis |
|
| Lupus érythémateux disséminé chez l'enfant : recommandations concernant les examens à effectuer lors de l'évaluation initiale et du suivi |
|
| Lymphomes chez l'enfant infecté par le VIH-1 |
|
| Maladie de Still |
|
| [Massive fetomaternal hemorrhage and prevention of fetomaternal Rhesus incompatibility. The failure of our present system of prevention] |
|
| Morphologic and immunohistochemical characterization of granulomas in the nucleotide oligomerization domain 2–related disorders Blau syndrome and Crohn disease |
|
| MRI assessment of tenosynovitis in children with juvenile idiopathic arthritis: inter- and intra-observer variability |
|
| [Musculoskeletal pain: diagnostic possibilities] |
|
| Myasthénie néonatale transitoire chez le prématuré: difficulté du diagnostic et intérêt du traitement anticholinestérasique |
|
| Occurrence of inflammatory bowel disease during treatment of juvenile idiopathic arthritis with etanercept: a French retrospective study. |
|
| Outcome of children with panarteritis nodosa: a series of 30 cases |
|
| P03-018 - Diversity in presenting manifestations of AUTOINFL. |
|
| Pathophysiologie des défauts génétiques du Lupus Erythémateux disséminé pédiatrique : implications du stress du réticulum endoplasmique et de la voie PI3K dans le développement de l'auto-immunité |
|
| Pediatric systemic lupus erythematosus and human parvovirus B19 infection |
|
| Pharmacovigilance in juvenile idiopathic arthritis patients (Pharmachild) treated with biologic agents and/or methotrexate. Consolidated baseline characteristics from Pharmachild and other national registries |
|
| The Phenotype and Genotype of Mevalonate Kinase Deficiency: A Series of 114 Cases From the Eurofever Registry |
|
| Predominant role of IgM-dependent activation of the classical pathway in the clearance of dying cells by murine bone marrow-derived macrophagesin vitro |
|
| PReS-FINAL-2103: Real life management of VZV infection or reactivation in rheumatic children on biologics: the French experience |
|
| PReS-FINAL-2157: Efficacy of canakinumab in the treatment of systemic juvenile idiopathic arthritis: a 12-week pooled post-hoc analysis |
|
| PReS-FINAL-2161: Safety and effectiveness of adalimumab in children with polyarticular juvenile idiopathic arthritis aged 2 to <4 years or >=4 years weighing <15 kg. |
|
| PReS-FINAL-2180: Efficacy and safety of tocilizumab |
|
| PReS-FINAL-2191: Imaging of chronic recurrent multifocal osteitis: a french national cohort of 178 cases. |
|
| PReS-FINAL-2231: A series of 41 mutations of TNFRAF1A. |
|
| PReS-FINAL-2311: Rituximab in paediatric ANCA-associated vasculitis. |
|
| Primary Cytomegalovirus Infection, Atypical Kawasaki Disease, and Coronary Aneurysms in 2 Infants |
|
| Primary T-cell immunodeficiency with immunodysregulation caused by autosomal recessive LCK deficiency. |
|
| Probable DRESS syndrome induced by IL-1 inhibitors |
|
| Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part two: Genoa, Italy. 28 September – 01 October 2016. |
|
| Progressive polyepiphyseal dysplasia with arthropathy: A distinct disorder from idiopathic juvenile arthritis and pseudorheumatoid dysplasia? |
|
| Propionibacterium acnes Chest Infections in Patients with Chronic Granulomatous Disease: Case Reports |
|
| PW02-027 - CAPS and cost-effectiveness analysis project |
|
| PW03-033 - SLC29A3 mutation: a new autoinflammatory condition. |
|
| The RaDiCEA Project: cost of illness |
|
| Radiological peripheral involvement in a cohort of patients with polyarticular juvenile idiopathic arthritis at adulthood |
|
| Raynaud's phenomenon in children |
|
| Recherche qualitative phénoménologique et interprétative (IPA) appliquée aux questions somatiques en médecine et santé de l'adolescent |
|
| Recommandations pour la prise en charge des formes oligoarticulaire et polyarticulaires (en dehors de la polyarthrite rhumatoïde) d’arthrite juvénile idiopathique |
|
| Relapses of childhood anaplastic large-cell lymphoma: Treatment results in a series of 41 children - a report from the French Society of Pediatric Oncology |
|
| Relationship Between Antiretroviral Drug Plasma Concentrations and Viral Load in Children |
|
| Results from a multicentre international registry of familial Mediterranean fever: impact of environment on the expression of a monogenic disease in children |
|
| RNA recognition by human TLR8 can lead to autoimmune inflammation |
|
| Rôle de la plasticité vasculaire dans le remodelage musculaire chez l’enfant. |
|
| Role of vascular plasticity in muscle remodeling in the child |
|
| Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry |
|
| Safety of rituximab in children with auto-immune diseases. |
|
| Severe cardiac involvement in children with systemic sclerosis and myositis. |
|
| Share – Workpackage 5: evidence based recommendations for diagnosis and treatment of juvenile idiopathic arthritis. |
|
| Sicca syndrome and salivary gland infiltration in children with autoimmune disorders: when can we diagnose Sjögren syndrome? |
|
| Systemic onset Juvenile Idiopathic Arthritis (SoJIA): a monocentric study of 114 patients. |
|
| Systemic-onset juvenile rheumatoid arthritis and ANCA-associated glomerulonephritis. |
|
| T-cell-depleted HLA non-identical bone marrow transplantation in the child: prevention of graft-versus-host reaction by administration of donor T lymphocytes alloreactive against the recipient |
|
| Tolerance of efavirenz in children. |
|
| Treating to target of minimal disease activity and normal function in polyarticular juvenile idiopathic arthritis with adalimumab: analysis from a phase 3 clinical trial |
|
| Treatment of childhood autoimmune haemolytic anaemia with rituximab |
|
| Urgences en rhumatologie pédiatrique |
|
| Use of canakinumab in the cryopyrin-associated periodic syndrome |
|
| Use of the JADAS criteria to assess efficacy of canakinumab in patients with SJIA – an analysis of 12-week pooled data |
|
| Les uvéites : les réponses claires des spécialistes des uvéites |
|
| Uveitis Related to Juvenile Idiopathic Arthritis: Familial Cases and Possible Genetic Implication in the Pathogenesis |
|
| Validation of the French version of the Childhood Health Assessment Questionnaire (CHAQ) in juvenile idiopathic arthritis |
|
| Vasculopathy-related clinical and pathological features are associated with severe juvenile dermatomyositis. |
|
| When should we use TNF antagonists in children with rheumatic disease? |
|
